Advertisement
Screener

Immunoclin Corp Forms 3, 4 and 5: Stock Options

Immunoclin Corp Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 8 rows, 8 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2015-06-18: Reporting owner Bray DH; Form 4/A; Security Common Stock Options; Transaction Holding.
  • 2015-06-12: Reporting owner Benlhassan Khadija; Form 4; Security Common Stock Options; Transaction Holding.
  • 2015-06-09: Reporting owner Bray DH; Form 4; Security Common Stock Options; Transaction Holding.
  • 2015-06-09: Reporting owner JOHNSON CHAD STEVEN; Form 4; Security Common Stock Options; Transaction Holding.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2015-06-18
holding as of filing
Bray DH
Director, Officer (President, CEO), 10% Owner
4/ACommon Stock Options
Derivative · Direct
Holding
1,000,000 owned after
$1.45
exercise price
2015-06-18
2015-06-12
holding as of filing
Benlhassan Khadija
Director, Officer (Chief Scientific Officer)
4Common Stock Options
Derivative · Indirect · Held by KBLH Holding BV, a company which Dr. Benlhassan has voting and investment control over
Holding
1,000,000 owned after
$1.45
exercise price
2015-06-12
2015-06-09
holding as of filing
Bray DH
Director, Officer (President, CEO), 10% Owner
4Common Stock Options
Derivative · Direct
Holding
1,000,000 owned after
$1.45
exercise price
2015-06-09
2015-06-09
holding as of filing
JOHNSON CHAD STEVEN
Director, Officer (Secretary/COO/General Counsel)
4Common Stock Options
Derivative · Direct
Holding
500,000 owned after
$1.45
exercise price
2015-06-09
2015-01-01JOHNSON CHAD STEVEN
Director, Officer (Secretary/COO/General Counsel)
4Common Stock Options
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+500,000
500,000 owned after
$1.452015-01-15
2014-11-01Bray DH
Director, Officer (President, CEO), 10% Owner
4/ACommon Stock Options
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,000,000
1,000,000 owned after
$1.452015-06-18
2014-11-01Bray DH
Director, Officer (President, C.E.O.), 10% Owner
4Common Stock Options
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,000,000
1,000,000 owned after
$1.452014-11-06
2014-11-01MUNRO JAMES SCOTT
Officer (CFO, Treasurer)
4Common Stock Options
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,000,000
1,000,000 owned after
$1.452014-11-05